We are live on ! Find out more
REPL icon

Replimune Group
REPL

106 hedge funds and large institutions have $704M invested in Replimune Group in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 48 increasing their positions, 26 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 26

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

4% more funds holding

Funds holding: 102 → 106 (+4)

1.15% more ownership

Funds ownership: 81.52% → 82.66% (+1.1%)

1% more capital invested

Capital invested by funds: $696M → $704M (+$7.51M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
106
Holders Change
+4
Holders Change %
+3.92%
% of All Funds
1.83%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
12
Increased
48
Reduced
26
Closed
8
Calls
$2.75M
Puts
–
Net Calls
+$2.75M
Net Calls Change
+$417K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$8.43M
2
GPP
Great Point Partners
Connecticut
+$7.44M
3
BBA
Baker Bros. Advisors
New York
+$5.77M
4
Ameriprise
Ameriprise
Minnesota
+$4.13M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.32M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$32.6M
2
OFM
Omega Fund Management
Massachusetts
-$7.35M
3
State Street
State Street
Massachusetts
-$3.81M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.25M
5
PAM
Panagora Asset Management
Massachusetts
-$1.99M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$3.74M +$4.13M +216,669 New
IHAM
27
Integral Health Asset Management
New York
$3.45M -$366K -19,194 -9%
Goldman Sachs
28
Goldman Sachs
New York
$3.19M -$777K -40,724 -18%
JP Morgan Chase
29
JP Morgan Chase
New York
$2.85M +$2.58M +135,173 +455%
NFGH
30
Nan Fung Group Holdings
Hong Kong
$2.68M – – –
Bank of New York Mellon
31
Bank of New York Mellon
New York
$2.53M +$795K +41,668 +40%
Renaissance Technologies
32
Renaissance Technologies
New York
$2.42M -$514K -26,953 -16%
Millennium Management
33
Millennium Management
New York
$2.38M +$689K +36,147 +35%
Deutsche Bank
34
Deutsche Bank
Germany
$2.35M +$31K +1,626 +1%
N
35
Nuveen
North Carolina
$2.35M -$147K -7,689 -5%
OCM
36
Osterweis Capital Management
California
$2.15M -$275K -14,445 -10%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$2.12M -$238K -12,500 -9%
TD Asset Management
38
TD Asset Management
Ontario, Canada
$1.75M – – –
Norges Bank
39
Norges Bank
Norway
$1.58M – – –
Two Sigma Investments
40
Two Sigma Investments
New York
$1.46M +$466K +24,427 +41%
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.3M -$4.37K -229 -0.3%
Rafferty Asset Management
42
Rafferty Asset Management
New York
$1.28M +$329K +17,263 +30%
Bank of America
43
Bank of America
North Carolina
$1.23M +$168K +8,812 +14%
Citigroup
44
Citigroup
New York
$1.21M +$189K +9,927 +17%
Point72 Asset Management
45
Point72 Asset Management
Connecticut
$1.21M -$2.25M -117,975 -63%
PAM
46
Panagora Asset Management
Massachusetts
$1.16M -$1.99M -104,259 -61%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$1.02M +$285K +14,971 +34%
Swiss National Bank
48
Swiss National Bank
Switzerland
$1M +$49.6K +2,600 +5%
Fisher Asset Management
49
Fisher Asset Management
Washington
$954K +$1.05M +55,258 New
Ensign Peak Advisors
50
Ensign Peak Advisors
Utah
$935K +$383K +20,110 +59%
1
2
3 4 5

REPL Hedge Fund Activity: Q3 2022 in Review

106 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q3 2022, worth a combined $704M — up 1.1% from $696M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new REPL positions and 8 closed out — a net gain of 4 holders — while 48 added to existing stakes and 26 trimmed.

The largest buyer was BlackRock, adding an estimated $8.43M. The largest seller was T. Rowe Price Associates, cutting an estimated $32.6M.

  • 106 institutional investors held Replimune Group (REPL) as of Q3 2022, up from 102 in Q2 2022.
  • Funds reported $704M of Replimune Group stock for Q3 2022, up 1.1% quarter-over-quarter.
  • 12 funds opened new Replimune Group positions in Q3 2022 and 8 closed out, a net change of +4 holders.
  • The largest Replimune Group buyer in Q3 2022 was BlackRock, an estimated $8.43M added.
  • The largest Replimune Group seller in Q3 2022 was T. Rowe Price Associates, an estimated $32.6M sold.

Based on aggregated 13F filings for Q3 2022.